Identification and validation of seven new loci showing differential DNA methylation related to serum lipid profile: An epigenome-wide approach. The REGICOR study

Human Molecular Genetics

Volumn 25, Issue 20, 2016, Pages 4556-4565

  Sayols Baixeras, S ^a,b   Subirana, I ^a,c   Lluis Ganella, C ^a   Civeira, F ^d   Roquer, J ^a   Do, A N ^e   Absher, D ^f   Cenarro, A ^d   Munoz D ^a   Soriano Tarraga C ^a   Jimenez Conde J ^a   Ordovas, J M ^g   Senti, M ^b   Aslibekyan, S ^e   Marrugat, J ^a   Arnett, D K ^h   Elosua, R ^a  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^g TUFTS UNIVERSITY   (United States)

^h UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER G1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SPACER DNA; THIOREDOXIN INTERACTING PROTEIN; TRIACYLGLYCEROL; ABCG1 PROTEIN, HUMAN; AMINO ACID TRANSPORTER; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE 1A, HUMAN; CARRIER PROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MYLIP PROTEIN, HUMAN; PHOSPHATASE; PHOSPHO1 PROTEIN, HUMAN; SLC7A11 PROTEIN, HUMAN; SREBF1 PROTEIN, HUMAN; SREBF2 PROTEIN, HUMAN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; SYNGAP1 PROTEIN, HUMAN; TXNIP PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ADULT; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 2; CPG ISLAND; CPT1A GENE; DNA METHYLATION; EPIGENETICS; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYLIP GENE; PHOSPHO1 GENE; PRIORITY JOURNAL; SLC7A11 GENE; SREBF1 GENE; SREBF2 GENE; SYNGAP1 GENE; TRANSCRIPTOMICS; TRIACYLGLYCEROL BLOOD LEVEL; VALIDATION STUDY; BLOOD; CARDIOVASCULAR DISEASE; CHEMISTRY; DNA SEQUENCE; ENZYMOLOGY; GENETIC ASSOCIATION STUDY; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; METABOLISM;

AMINO ACID TRANSPORT SYSTEM Y+; ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY G, MEMBER 1; CARDIOVASCULAR DISEASES; CARNITINE O-PALMITOYLTRANSFERASE; CARRIER PROTEINS; CHOLESTEROL; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPID METABOLISM; MALE; PHOSPHORIC MONOESTER HYDROLASES; RAS GTPASE-ACTIVATING PROTEINS; SEQUENCE ANALYSIS, DNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIGLYCERIDES; UBIQUITIN-PROTEIN LIGASES;

EID: 85010965742     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw285     Document Type: Article

References (52)

1. O'Donnell, C.J. and Elosua, R. (2008) Cardiovascular risk factors. Insights from Framingham Heart Study. Rev. Esp. Cardiol., 61, 299-310.
2. Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., de Ferranti, S., Despres, J.P., Fullerton, H.J., Howard, V.J., et al. (2014) Heart Disease and Stroke Statistics-2015 Update: A Report From the American Heart Association. Circulation, 131, e29-e294.
3. Sayols-Baixeras, S., Lluis-Ganella, C., Lucas, G. and Elosua, R. (2014) Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. Appl. Clin. Genet., 7, 15-32.
4. Martinez-Jimenez, C.P. and Sandoval, J. (2015) Epigenetic crosstalk: a molecular language in human metabolic disorders. Front. Biosci. (Schol. Ed.), 7, 46-57.
5. Irvin, M.R., Zhi, D., Joehanes, R., Mendelson, M., Aslibekyan, S., Claas, S.A., Thibeault, K.S., Patel, N., Day, K., Jones, L.W., et al. (2014) Epigenome-wide association study of fasting blood lipids in the genetics of lipid-lowering drugs and diet network study. Circulation, 130, 565-572.
6. Pfeiffer, L., Wahl, S., Pilling, L.C., Reischl, E., Sandling, J.K., Kunze, S., Holdt, L.M., Kretschmer, A., Schramm, K., Adamski, J., et al. (2015) DNA methylation of lipid-related genes affects blood lipid levels. Circ. Cardiovasc. Genet., 8, 334-342.
7. Guay, S.P., Voisin, G., Brisson, D., Munger, J., Lamarche, B., Gaudet, D. and Bouchard, L. (2012) Epigenome-wide analysis in familial hypercholesterolemia identified new loci associated with high-density lipoprotein cholesterol concentration. Epigenomics, 4, 623-639.
8. Guay, S.P., Brisson, D., Lamarche, B., Gaudet, D. and Bouchard, L. (2014) Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia. Epigenetics, 9, 718-729.
9. Guay, S.P., Brisson, D., Munger, J., Lamarche, B., Gaudet, D. and Bouchard, L. (2012) ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia. Epigenetics, 7, 464-472.
10. Peng, P., Wang, L., Yang, X., Huang, X., Ba, Y., Chen, X., Guo, J., Lian, J. and Zhou, J. (2014) A preliminary study of the relationship between promoter methylation of the ABCG1, GALNT2 and HMGCR genes and coronary heart disease. PLoS One, 9, 1-8.
11. Guay, S.P., Légaré, C., Houde, A.A., Mathieu, P., Bossé, Y. and Bouchard, L. (2014) Acetylsalicylic acid, aging and coronary artery disease are associated with ABCA1 DNA methylation in men. Clin. Epigenetics, 6, 1-7.
12. Demerath, E.W., Guan, W., Grove, M.L., Aslibekyan, S., Mendelson, M., Zhou, Y.H., Hedman, AK., Sandling, J.K., Li, L.A., Irvin, M.R., et al. (2015) Epigenome-wide Association Study (EWAS) of BMI, BMI Change, and Waist Circumference in African American Adults Identifies Multiple Replicated Loci. Hum. Mol. Genet., 24, 4464-4479.
13. Aslibekyan, S., Demerath, E.W., Mendelson, M., Zhi, D., Guan, W., Liang, L., Sha, J., Pankow, J.S., Liu, C., Irvin, M.R., et al. (2015) Epigenome-wide study identifies novel methylation loci associated with body mass index and waist circumference. Obesity, 23, 1493-1501.
14. Robinet, P., Vé die, B., Chironi, G. and Gariépy, J. (2003) Characterization of polymorphic structure of SREBP-2 gene: role in atherosclerosis. Atherosclerosis, 168, 381-387.
15. Kiffer-Moreira, T., Yadav, M.C., Zhu, D., Narisawa, S., Sheen, C., Stec, B., Cosford, N.D., Dahl, R., Farquharson, C., Hoylaerts, M.F., et al. (2013) Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification. J. Bone Miner. Res., 28, 81-91.
16. Bobryshev, Y.V., Orekhov, A.N., Sobenin, I. and Chistiakov, D.A. (2014) Role of bone-type tissue-nonspecific alkaline phosphatase and PHOSPO1 in vascular calcification. Curr. Pharm. Des., 20, 5821-5828.
17. Kulkarni, H., Kos, M.Z., Neary, J., Dyer, T.D., Göring, H.H.H., Cole, S.A., Comuzzie, A.G., Almasy, L., Mahaney, M.C., Curran, J.E., et al. (2015) Novel epigenetic determinants of type 2 diabetes in mexican american families. Hum. Mol. Genet., 24, 5330-5344.
18. Chambers, J.C., Loh, M., Lehne, B., Drong, A., Kriebel, J., Motta, V., Wahl, S., Elliott, H.R., Rota, F., Scott, W.R., et al. (2015) Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol., 3, 526-534.
19. Bjornstad, P., Eckel, R.H., Pyle, L., Rewers, M., Maahs, D.M. and Snell-Bergeon, J.K. (2015) Relation of combined nonhigh-density lipoprotein cholesterol and apolipoprotein B with atherosclerosis in adults with type 1 diabetes mellitus. Am. J. Cardiol., 116, 1057-1062.
20. Eren, E., Ellidag, H.Y., Aydin, O. and Yilmaz, N. (2014) HDLAssociated paraoxonase 1 as a bridge between postmenopausal osteoporosis and cardiovascular disease. Chonnam. Med. J., 50, 75-81.
21. Rattazzi, M., Faggin, E., Buso, R., Di Virgilio, R., Puato, M., Plebani, M., Zaniotto, M., Palmosi, T., Bertacco, E., Fadini, G.P., et al. (2016) Atorvastatin reduces circulating osteoprogenitor cells and T-Cell RANKL expression in osteoporotic women: implications for the bone-vascular axis. Cardiovasc. Ther., 34, 13-20.
22. García-Sánchez, C., Posadas-Romero, C., Posadas-Sánchez, R., Carreón-Torres, E., Rodríguez-Pé rez, J.M., Juárez-Rojas, J.G., Martínez-Sánchez, C., Fragoso, J.M., González-Pacheco, H., Vargas-Alarcón, G., et al. (2015) Low concentrations of phospholipids and plasma HDL cholesterol subclasses in asymptomatic subjects with high coronary calcium scores. Atherosclerosis, 238, 250-255.
23. Parikh, H., Carlsson, E., Chutkow, W.A., Johansson, L.E., Storgaard, H., Poulsen, P., Saxena, R., Ladd, C., Schulze, P.C., Mazzini, M.J., et al. (2007) TXNIP regulates peripheral glucose metabolism in humans. PLoS Med, 4, 0868-0879.
24. Zhou, J. and Chang, W.J. (2013) Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer. Mitochondrion, 13, 163-169.
25. Florath, I., Butterbach, K., Heiss, J., Bewerunge-Hudler, M., Zhang, Y., Schöttker, B. and Brenner, H. (2016) Type 2 diabetes and leucocyte DNA methylation: an epigenome-wide association study in over 1, 500 older adults. Diabetologia, 59, 130-138.
26. Soriano-Tárraga, C., Jiménez-Conde, J., Giralt-Steinhauer, E., Mola-Caminal, M., Vivanco-Hidalgo, R.M., Ois, A., Rodríguez-Campello, A., Cuadrado-Godia, E., Sayols-Baixeras, S., Elosua, R., et al. (2015) Epigenome-wide association study identifies TXNIP gene associated with type 2 diabetes mellitus and sustained hyperglycemia. Hum. Mol. Genet., 25, 609-619.
27. Bodnar, J.S., Chatterjee, A., Castellani, L.W., Ross, D.A., Ohmen, J., Cavalcoli, J., Wu, C., Dains, K.M., Catanese, J., Chu, M., et al. (2002) Positional cloning of the combined hyperlipidemia gene Hyplip1. Nat. Genet., 30, 110-116.
28. Coon, H., Singh, N., Dunn, D., Eckfeldt, J.H., Province, M.A., Hopkins, P.N., Weiss, R., Hunt, S.C. and Leppert, M.F. (2004) TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study. Atherosclerosis, 174, 357-362.
29. Pajukanta, P., Lilja, H.E., Sinsheimer, J.S., Cantor, R.M., Lusis, A.J., Gentile, M., Duan, X.J., Soro-Paavonen, A., Naukkarinen, J., Saarela, J., et al. (2004) Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat. Genet., 36, 371-376.
30. Van der Vleuten, G.M., Hijmans, A., Kluijtmans, L.A., Blom, H.J., Utalenhoef, A.F. and de Graaf, J. (2004) Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemia. Am. J.Med. Genet. A., 130, 73-75.
31. Van Greevenbroek, M.M.J., Vermeulen, V.M.M.J., Feskens, E.J.M., Evelo, C.T., Kruijshoop, M., Hoebee, B., van der Kallen, C.J.H. and de Bruin, TW. a. (2007) Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus. Diabet. Med., 24, 498-504.
32. Teslovich, T.M., Musunuru, K., Smith, A.V., Edmondson, A.C., Stylianou, I.M., Koseki, M., Pirruccello, J.P., Ripatti, S., Chasman, D.I., Willer, C.J., et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature, 466, 707-713.
33. Global Lipids Genetics Consortium(2013) Discovery and refinement of loci associated with lipid levels. Nat. Genet., 45, 1274-1283.
34. Lindholm, D., Bornhauser, B.C. and Korhonen, L. (2009) Mylip makes an Idol turn into regulation of LDL receptor. Cell. Mol. Life Sci., 66, 3399-3402.
35. Raal, F.J., Stein, E.A., Dufour, R., Turner, T., Civeira, F., Burgess, L., Langslet, G., Scott, R., Olsson, A.G., Sullivan, D., et al. (2015) PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial. Lancet, 385, 331-340.
36. Relton, C.L. and Davey Smith, G. (2015) Mendelian randomization: applications and limitations in epigenetic studies. Epigenomics, 7, 1239-1243.
37. Bibikova, M., Barnes, B., Tsan, C., Ho, V., Klotzle, B., Le, J.M., Delano, D., Zhang, L., Schroth, G.P., Gunderson, K.L., et al. (2011) High density DNA methylation array with single CpG site resolution. Genomics, 98, 288-295.
38. Sandoval, J., Heyn, H.A., Moran, S., Serra-Musach, J., Pujana, M.A., Bibikova, M. and Esteller, M. (2011) Validation of a DNA methylation microarray for 450, 000 CpG sites in the human genome. Epigenetics, 6, 692-702.
39. Yousefi, P., Huen, K., Schall, R.A., Decker, A., Elboudwarej, E., Quach, H., Barcellos, L. and Holland, N. (2013) Considerations for normalization of DNA methylation data by Illumina 450K BeadChip assay in population studies. Epigenetics, 8, 1141-1152.
40. Kannel, W.B., Feinleib, M., McNamara, P.M., Garrison, R.J. and Castelli, W.P. (1979) An investigation of coronary heart disease in families. The Framingham offspring study. Am. J. Epidemiol., 110, 281-290.
41. Du, P., Zhang, X., Huang, C.C., Jafari, N., Kibbe, W. a., Hou, L. and Lin, S.M. (2010) Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics, 11, 1-9.
42. Dedeurwaerder, S., Defrance, M., Bizet, M., Calonne, E., Bontempi, G. and Fuks, F. (2013) A comprehensive overview of Infinium HumanMethylation450 data processing. Brief. Bioinform., 15, 929-941.
43. Teschendorff, A.E., Zhuang, J. and Widschwendter, M. (2011) Independent surrogate variable analysis to deconvolve confounding factors in large-scale microarray profiling studies. Bioinformatics, 27, 1496-1505.
44. Houseman, E.A., Accomando, W.P., Koestler, D.C., Christensen, B.C., Marsit, C.J., Nelson, H.H., Wiencke, J.K. and Kelsey, K.T. (2012) DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics, 13, 1-16.
45. Aryee, M.J., Jaffe, A.E., Corrada-Bravo, H., Ladd-Acosta, C., Feinberg, A.P., Hansen, K.D. and Irizarry, R.A. (2014) Minfi: A flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics, 30, 1363-1369.
46. Leek, J.T., Johnson, W.E., Parker, H.S., Fertig, E.J., Jaffe, A.E. and Storey, J.D. sva: Surrogate Variable Analysis. R package version 3.10.0.
47. Corella, D., Arnett, D.K., Tsai, M.Y., Kabagambe, E.K., Peacock, J.M., Hixson, J.E., Straka, R.J., Province, M., Lai, C.Q., Parnell, L.D., et al. (2007) The-256T>C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study. Clin. Chem., 53, 1144-1152.
48. Absher, D.M., Li, X., Waite, L.L., Gibson, A., Roberts, K., Edberg, J., Chatham, W.W. and Kimberly, R.P. (2013) Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet., 9, e1003678.
49. Engstrom, P.G., Steijger, T., Sipos, B., Grant, G.R. and Kahles, A., The RGASP Consortium. (2013) Systematic evaluation of spliced alignment programs for RNA-Seq data. Nat. Methods, 10, 1185-1191.
50. Anders, S., Pyl, P.T. and Huber, W. (2015) HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics, 31, 166-169.
51. Ali, O., Cerjak, D., Kent, J.W.J., James, R., Blangero, J., Carless, M.A. and Zhang, Y. (2015) An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome. Clin. Epigenetics, 7, 12.
52. Arner, P., Sinha, I., Thorell, A., Rydén, M., Dahlman-Wright, K. and Dahlman, I. (2015) The epigenetic signature of subcutaneous fat cells is linked to altered expression of genes implicated in lipid metabolism in obese women. Clin. Epigenetics, 7, 1-13.